Cargando…
NGR-peptide−drug conjugates with dual targeting properties
Peptides containing the asparagine-glycine-arginine (NGR) motif are recognized by CD13/aminopeptidase N (APN) receptor isoforms that are selectively overexpressed in tumor neovasculature. Spontaneous decomposition of NGR peptides can result in isoAsp derivatives, which are recognized by RGD-binding...
Autores principales: | Enyedi, Kata Nóra, Tóth, Szilárd, Szakács, Gergely, Mező, Gábor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5456102/ https://www.ncbi.nlm.nih.gov/pubmed/28575020 http://dx.doi.org/10.1371/journal.pone.0178632 |
Ejemplares similares
-
Development of novel cyclic NGR peptide–daunomycin conjugates with dual targeting property
por: Tripodi, Andrea Angelo Pierluigi, et al.
Publicado: (2018) -
NGR-Based Radiopharmaceuticals for Angiogenesis Imaging: A Preclinical Review
por: Trencsényi, György, et al.
Publicado: (2023) -
In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug Delivery
por: Tripodi, Andrea Angelo Pierluigi, et al.
Publicado: (2019) -
In Vivo Molecular Imaging of the Efficacy of Aminopeptidase N (APN/CD13) Receptor Inhibitor Treatment on Experimental Tumors Using (68)Ga-NODAGA-c(NGR) Peptide
por: Kis, Adrienn, et al.
Publicado: (2021) -
On the design principles of peptide–drug conjugates for targeted drug delivery to the malignant tumor site
por: Vrettos, Eirinaios I, et al.
Publicado: (2018)